Patents by Inventor Edwin J. Whitney

Edwin J. Whitney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cholesterol-lowering therapy
    Publication number: 20020103251
    Abstract: Methods are described for preventing or reducing the risk of a first occurrence of a cardiovascular event using an HMG-CoA reductase inhibitor alone or in combination with another lipid altering agent. Subjects to be treated are those having an average serum total cholesterol level, an average to mildly elevated serum low-density lipoprotein cholesterol level, and a below average serum high-density lipoprotein cholesterol level, with no history of clinically evident coronary disease.
    Type: Application
    Filed: December 20, 2001
    Publication date: August 1, 2002
    Inventors: Edwin J. Whitney, Geraldine Mantell
  • Cholesterol-lowering therapy
    Publication number: 20010049388
    Abstract: Methods are described for preventing or reducing the risk of a first occurrence of a cardiovascular event using an HMG-CoA reductase inhibitor alone or in combination with another lipid altering agent. Subjects to be treated are those having an average serum total cholesterol level, an average to mildly elevated serum low-density lipoprotein cholesterol level, and a below average serum high-density lipoprotein cholesterol level, with no history of clinically evident coronary disease.
    Type: Application
    Filed: December 5, 2000
    Publication date: December 6, 2001
    Inventors: Edwin J. Whitney, Geraldine Mantell
  • Cholesterol-lowering therapy
    Patent number: 6180660
    Abstract: Methods are described for preventing or reducing the risk of a first occurrence of a cardiovascular event using an HMG-CoA reductase inhibitor alone or in combination with another lipid altering agent. Subjects to be treated are those having an average serum total cholesterol level, an average to mildly elevated serum low-density lipoprotein cholesterol level, and a below average serum high-density lipoprotein cholesterol level, with no history of clinically evident coronary disease.
    Type: Grant
    Filed: May 13, 1998
    Date of Patent: January 30, 2001
    Assignee: Merck & Co., Inc.
    Inventors: Edwin J. Whitney, Geraldine Mantell